×

Juno Therapeutics CEO on FDA greenlight

5:53 PM ET Tue, 12 July 2016

CNBC's Meg Tirrell speaks with Juno Therapeutics CEO Hans Bishop about the FDA's decision to take his company's immunotherapy trial off clinical hold.